Jiangsu, China

Fuping Liu

USPTO Granted Patents = 2 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovative Contributions of Fuping Liu in Cancer Treatment

Introduction: Fuping Liu, an accomplished inventor from Jiangsu, China, has significantly contributed to the field of pharmaceuticals through his innovative research. With a total of two patents to his name, Liu's work primarily focuses on developing effective treatments for diseases mediated by EGFR mutations.

Latest Patents: Liu's latest patents include the invention of an EGFR inhibitor free base or acid salt polycrystalline form, along with its preparation method and application. This invention specifically pertains to an N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide free base or acid salt polycrystalline form. The application of this polycrystalline form is vital in creating drugs to treat diseases associated with EGFR mutant activity, such as various types of cancer, particularly non-small cell lung cancer. Liu's inventions aim to inhibit the activities of specific EGFR mutants, including L858R, T790M, and exon 19 deletion activating mutants, representing a potential breakthrough in oncology.

Career Highlights: Throughout his career, Fuping Liu has been associated with esteemed organizations, including Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His expertise in drug development has made him a valuable asset within the pharmaceutical industry, enhancing therapeutic options for patients worldwide.

Collaborations: In his innovative journey, Liu has collaborated with notable colleagues, including Zhongke Chen and Lei Liu. These partnerships have fostered an environment of creativity and scientific inquiry, contributing to the advancement of cancer treatment solutions.

Conclusion: Fuping Liu stands as a testament to the impact of dedicated research and innovation in healthcare. His contributions, particularly in the realm of EGFR inhibitors, herald a new generation of treatments that hold promise for improving the lives of patients dealing with cancer-related challenges. Liu's commitment to advancing medical science reinforces the essential role of inventors in shaping a healthier future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…